In a retrospective study from UAE ( n = 63), oral supplementation of COVID-19 patients yielded no difference in vit-C levels across BMI categories
GLP-1 agonists as a class offer substantial benefits, including improved glycemic control, weight reduction, and cardiovascular protection, that millions of Americans have come to rely on, and semaglutide brands such as Ozempic and Wegovy have emerged as the drugs of choice for most patients
An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential association between steroid hormones and tumor cell proliferation
Glucagon-like peptide-1 mimetics improve certain cardiovascular risk factors, although it is unclear if the observed benefits are direct effects or indirect effects due to weight loss
Unlike prescription GLP-1 drugs such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), these supplements lack rigorous clinical evidence and regulatory oversight
,